- Mukka Proteins Limited (NSE: MUKKA) is raising ₹ 470 million through a preferential issue of 20 million fully convertible warrants priced at ₹ 23 each.
- The issuance will lift paid‑up share capital from 300 million to 320 million shares, adding 20 million new shares to the capital base.
- 15 investors (including Irfan Chapra, Reshma Chapra, Vishal Maniar, etc.) will receive the warrants, which are convertible into equity within 18 months of allotment, with a lapse date of 12 January 2028.
- Board approval was given on 12 June 2026, prior intimation filed on 9 June 2026, and all SEBI (ICDR) and Circular 9 (Sept 2015) requirements are satisfied, making the fund‑raising regulatory‑clean.
Mukka Proteins is raising about ₹470 million through fully convertible warrants, which will dilute existing shareholders by roughly 6.7%. In the short run the stock may dip modestly, but the capital could support growth, limiting any prolonged downside.
Sign in for impact outlook, horizons, comparables, and full intelligence analysis.
Forecast from comparable, historic events. Not investment advice.
Frism is a financial information and news discovery platform. We provide factual summaries and data correlations for educational and informational purposes only. Frism does not provide investment advice, buy/sell recommendations, or directional market outlooks. Users should consult a qualified financial advisor before making any investment decisions.
Frism Computing (OPC) Private Limited
#74, 15TH CROSS, JP Nagar III Phase, Bangalore South, Bangalore 560078, Karnataka